SCHEMBL177563

SCHEMBL177563

Nc1ccc(CO[C]=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 2/20 0.44
GFER P55789 1/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAOB P27338 9/20 0.42
APP P05067 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.42
MAOA P21397 3/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
RECQL P46063 1/20 0.36
FDPS P14324 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17803243 0.83 TAAR1 (0.50) ALDH1A1TSHRTDP1MAOBLOXL2
SCHEMBL17803203 0.82 ABAT (0.46) MAOBLOXL2MAPTCA2CA9
SCHEMBL3092949 0.79 IDO1 (0.50) ALDH1A1APPL3MBTL1CA2MEN1
SCHEMBL5544629 0.78 GFER (0.52) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL8816 0.77 IDO1 (0.52) ALDH1A1MAOBAPPMAOAMAPT
SCHEMBL513966 0.77 CYP3A4 (0.52) CYP3A4APP
SCHEMBL513841 0.77 AGXT (0.52) ALDH1A1MAOBMAOAMAPTRAB9A
SCHEMBL95538 0.77 IDO1 (0.52) MAOBAPPLOXL2MAOACA2
SCHEMBL8480 0.77 IDO1 (0.52) ALDH1A1MAOBAPPMAOAMAPT
SCHEMBL6949336 0.77 RXRA (0.42) ALDH1A1TSHRTDP1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4048 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043670-B2 Anti-BCMA antibody-drug conjugates and methods of use EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-07-23 US claimed
US-20240239885-A1 ANTIBODY CONJUGATE COMPRISING ANTI-P-CADHERIN ANTIBODY AND USES THEREOF WuXi Biologics Ireland Limited (IE) 2024-07-18 US claimed
CN-118339165-A Antibody-drug conjugates and methods of use thereof R.P.谢勒技术有限责任公司 2024-07-12 CN claimed
EP-4392077-A2 TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2 (TACSTD2) ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF R.P. Scherer Technologies, LLC (US) 2024-07-03 EP claimed
EP-4392456-A2 ANTIBODIES HAVING HUMANIZED FRAMEWORK REGIONS R.P. Scherer Technologies, LLC (US) 2024-07-03 EP claimed
EP-4393515-A1 ANTI-CLDN-18.2 ANTIBODY-DRUG CONJUGATE AND USE THEREOF Shanghai Junshi Biosciences Co., Ltd. (CN) 2024-07-03 EP claimed
US-12023316-B2 FAP-activated therapeutic agents, and uses related thereto BACH BIOSCIENCES, LLC (US) 2024-07-02 US claimed
CN-113967258-B FAP-activated therapeutic agents and related uses 塔夫茨大学信托人 2024-07-02 CN claimed
WO-2024133815-A1 ANTIBODY-DRUG CONJUGATES WITH MASKED PBD DIMERS SYNAFFIX B.V. (NL) 2024-06-27 WO claimed
US-20240207418-A1 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. 2024-06-27 US claimed
US-20070003589-A1 Coatings for implantable medical devices containing attractants for endothelial cells ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2007-01-04 US claimed
WO-2006112932-A2 COATINGS FOR IMPLANTABLE MEDICAL DEVICES CONTAINING ATTRACTANTS FOR ENDOTHELIAL CELLS ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2006-10-26 WO claimed
US-20060116422-A1 Prodrugs built as multiple self-elimination-release spacers SYNTARGA B.V. (NL) 2006-06-01 US claimed
US-20050233948-A1 Drug complex for treatment of metastatic prostate cancer BETH ISRAEL DEACONESS MEDICAL CENTER (US) 2005-10-20 US claimed
EP-0799827-B1 ACRYLAMIDE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME KYORIN SEIYAKU KK (JP) 2004-05-12 EP claimed
US-20030195152-A1 Polymeric conjugates of antitumor agents PHARMACIA ITALIA, S.P.A. (IT) 2003-10-16 US claimed
EP-1317287-A2 POLYMERIC CONJUGATES OF ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2003-06-11 EP claimed
US-20030035804-A1 Drug complex for treatment of metastatic prostate cancer BETH ISRAEL DEACONESS MEDICAL CENTER (US) 2003-02-20 US claimed
WO-2002007770-A2 POLYMERIC CONJUGATES OF ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2002-01-31 WO claimed
US-4169939-A PROCESSES FOR THE PRODUCTION OF 3',4'-DIDEOXYKANAMYCIN B ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1979-10-02 US claimed